G16B 40/00
Ict specially adapted for biostatistics
Official title: ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
G16B40/00 (Ict specially adapted for biostatistics) appears on 3,296 US grants and 8,635 published applications in this corpus.
Search patents in G16B- Granted patents
- 3,296
- Published applications
- 8,635
- Assignees
- 2,643
- Inventors
- 15,416
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 8 | 0 |
| 2000 | 10 | 0 |
| 2001 | 9 | 5 |
| 2002 | 19 | 65 |
| 2003 | 12 | 111 |
| 2004 | 20 | 117 |
| 2005 | 27 | 140 |
| 2006 | 40 | 110 |
| 2007 | 24 | 117 |
| 2008 | 35 | 121 |
| 2009 | 28 | 100 |
| 2010 | 61 | 123 |
| 2011 | 74 | 159 |
| 2012 | 83 | 135 |
| 2013 | 75 | 191 |
| 2014 | 81 | 260 |
| 2015 | 83 | 178 |
| 2016 | 87 | 265 |
| 2017 | 104 | 282 |
| 2018 | 136 | 364 |
| 2019 | 208 | 574 |
| 2020 | 206 | 596 |
| 2021 | 215 | 616 |
| 2022 | 341 | 725 |
| 2023 | 343 | 819 |
| 2024 | 355 | 828 |
| 2025 | 332 | 912 |
| 2026 | 272 | 722 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- System and method for determining an immune activation state6 Oct 2026US 12,752,274 B2CytoVale Inc.
- Analyte characterization via iterative analysis6 Oct 2026US 12,754,188 B2Nautilus Subsidiary, Inc.
- Molecular profiling of tumors6 Oct 2026US 12,754,193 B2Caris MPI, Inc.
- Optimization of genetic sequences6 Oct 2026US 12,755,812 B1Nanil Therapeutics Inc.
- Generating virtual perturbed cells utilizing a latent transfer perturbation neural network6 Oct 2026US 12,755,813 B1Recursion Pharmaceuticals, Inc.
- Method and apparatus for providing data processing and control in medical communication system8 Oct 2026US 2026/0305986 A1Abbott Diabetes Care Inc.
- Multiple-tiered screening and second analysis8 Oct 2026US 2026/0308698 A1Flagship Pioneering Innovations VI, LLC
- Systems and Methods For The Identification And Characterization Of Pathogens In Urine Samples To Inform Patient Treatment8 Oct 2026US 2026/0308700 A1Biotia, Inc.
- Electrochemical biosensors, systems, and methods of use8 Oct 2026US 2026/0309671 A1
- System and Method for Single Protein Detection by Digital Plasmonic Nanobubbles8 Oct 2026US 2026/0309704 A1Board of Regents, The University of Texas System
Most cited
By later US patents
- Patient classification703US 6,763,307 B2Bioseek, Inc. · 2004
- Human thrombospondin polypeptide348US 7,745,391 B2Compugen Ltd. · 2010
- Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing246US 5,871,697 ACuraGen Corporation · 1999
- System and method for improving clinical decisions by aggregating, validating and analysing genetic and phenotypic data219US 8,024,128 B2Gene Security Network, Inc. · 2011
- Prediction of prostate cancer progression by analysis of selected predictive parameters195US 6,025,128 ACytodiagnostics, Inc. · 2000